Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Antihypertensive effects of statins: a meta-analysis of prospective controlled studies.

Briasoulis A, Agarwal V, Valachis A, Messerli FH.

J Clin Hypertens (Greenwich). 2013 May;15(5):310-20. doi: 10.1111/jch.12081. Epub 2013 Mar 7.

2.

The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials.

Banach M, Nikfar S, Rahimi R, Bielecka-Dabrowa A, Pencina MJ, Mikhailidis DP, Narkiewicz K, Rysz J, Ray KK, Abdollahi M; Lipid and Blood Pressure Meta-Analysis Collaboration Group.

Int J Cardiol. 2013 Oct 3;168(3):2816-24. doi: 10.1016/j.ijcard.2013.03.068. Epub 2013 Apr 18.

PMID:
23602289
4.
5.

Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials.

Strazzullo P, Kerry SM, Barbato A, Versiero M, D'Elia L, Cappuccio FP.

Hypertension. 2007 Apr;49(4):792-8. Epub 2007 Feb 19.

6.
8.

Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial.

Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH.

Arch Intern Med. 2008 Apr 14;168(7):721-7. doi: 10.1001/archinte.168.7.721.

10.

A meta-analysis of randomized controlled trials of azilsartan therapy for blood pressure reduction.

Takagi H, Mizuno Y, Niwa M, Goto SN, Umemoto T.

Hypertens Res. 2014 May;37(5):432-7. doi: 10.1038/hr.2013.142. Epub 2013 Oct 10.

PMID:
24108238
11.

Statins in hypertension: are they a new class of antihypertensive agents?

Feldstein CA.

Am J Ther. 2010 May-Jun;17(3):255-62. doi: 10.1097/MJT.0b013e3181c0695e.

PMID:
19918164
12.

Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).

Li JJ, Lu ZL, Kou WR, Chen Z, Wu YF, Yu XH, Zhao YC; Chinese Coronary Secondary Prevention Study (CCSPS) Group.

Clin Exp Hypertens. 2010;32(8):491-8. doi: 10.3109/10641961003686427.

PMID:
21091365
13.

Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis.

Johansson K, Sundström J, Neovius K, Rössner S, Neovius M.

Obes Rev. 2010 Nov;11(11):777-91. doi: 10.1111/j.1467-789X.2009.00693.x. Review.

PMID:
20025693
14.

Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia.

Borghi C, Prandin MG, Costa FV, Bacchelli S, Degli Esposti D, Ambrosioni E.

J Cardiovasc Pharmacol. 2000 Apr;35(4):549-55.

PMID:
10774784
15.

Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.

Malacco E, Omboni S, Mallion JM, Volpe M; ESPORT Study Group.

High Blood Press Cardiovasc Prev. 2012 Dec;19(4):213-22. doi: 10.1007/BF03297633. Epub 2013 Feb 19.

PMID:
23430666
16.

An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.

Miranda RD, Mion D Jr, Rocha JC, Kohlmann O Jr, Gomes MA, Saraiva JF, Amodeo C, Filho BL.

Clin Ther. 2008 Sep;30(9):1618-28. doi: 10.1016/j.clinthera.2008.09.008.

PMID:
18840367
19.

Spironolactone for hypertension.

Batterink J, Stabler SN, Tejani AM, Fowkes CT.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD008169. doi: 10.1002/14651858.CD008169.pub2. Review.

PMID:
20687095
20.

Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study.

Kanaki AI, Sarafidis PA, Georgianos PI, Stafylas PC, Kanavos K, Tziolas IM, Lasaridis AN.

J Hum Hypertens. 2012 Oct;26(10):577-84. doi: 10.1038/jhh.2011.80. Epub 2011 Sep 1.

PMID:
21881597

Supplemental Content

Support Center